Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Contains 0.9% (9 mg/mL) of benzyl alcohol added as a bacteriostatic preservative
While antibiotics are beneficial for Lyme disease, they may cause a Jarisch-Herxheimer reaction (JHR)
Erlotinib was first approved by the Food and Drug Administration on November 18, 2004, as a monotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Stem cell therapy for Peyronies disease avoids the use of invasive surgeries and can be administered through injections, which allows less recovery time
US$ 21.49
US$ 20.92
US$ 27.40
